Related references
Note: Only part of the references are listed.Health-related quality of life in men with osteoporosis: a systematic review and meta-analysis
Jing Hu et al.
ENDOCRINE (2021)
Association of Testosterone Therapy With Risk of Venous Thromboembolism Among Men With and Without Hypogonadism
Rob F. Walker et al.
JAMA INTERNAL MEDICINE (2020)
Emerging therapeutic targets for osteoporosis
Luigi Gennari et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2020)
Performance of predictive tools to identify individuals at risk of non-traumatic fracture: a systematic review, meta-analysis, and meta-regression
C. Beaudoin et al.
OSTEOPOROSIS INTERNATIONAL (2019)
The genetic architecture of osteoporosis and fracture risk
Katerina Trajanoska et al.
BONE (2019)
Executive Summary of the 2019 ISCD Position Development Conference on Monitoring Treatment, DXA Cross-calibration and Least Significant Change, Spinal Cord Injury, Peri-prosthetic and Orthopedic Bone Health, Transgender Medicine, and Pediatrics
Christopher R. Shuhart et al.
JOURNAL OF CLINICAL DENSITOMETRY (2019)
Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension
Steven R. Cummings et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
The role of previous falls in major osteoporotic fracture prediction in conjunction with FRAX in older Chinese men and women: the Mr. OS and Ms. OS cohort study in Hong Kong
Y. Su et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Protein Kinase G Activation Reverses Oxidative Stress and Restores Osteoblast Function and Bone Formation in Male Mice With Type 1 Diabetes
Hema Kalyanaraman et al.
DIABETES (2018)
New and developing pharmacotherapy for osteoporosis in men
Luigi Gennari et al.
EXPERT OPINION ON PHARMACOTHERAPY (2018)
Comparison of Methods for Improving Fracture Risk Assessment in Diabetes: The Manitoba BMD Registry
William D. Leslie et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Measures of Physical Performance and Muscle Strength as Predictors of Fracture Risk Independent of FRAX, Falls, and aBMD: A Meta-Analysis of the Osteoporotic Fractures in Men (MrOS) Study
Nicholas C. Harvey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
A Phase III Randomized Placebo-Controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis
E. Michael Lewiecki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Performance of FRAX in clinical practice according to sex and osteoporosis definitions: the Manitoba BMD registry
W. D. Leslie et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Bone Health After Bariatric Surgery
Claudia Gagnon et al.
JBMR PLUS (2018)
Mechanisms of diabetes mellitus-induced bone fragility
Nicola Napoli et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Kynurenine, a Tryptophan Metabolite That Accumulates With Age, Induces Bone Loss
Mona El Refaey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Screening for Osteoporosis in Older Men: Operating Characteristics of Proposed Strategies for Selecting Men for BMD Testing
Susan J. Diem et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2017)
Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures
N. C. W. Harvey et al.
OSTEOPOROSIS INTERNATIONAL (2017)
A Novel H2S-releasing Amino-Bisphosphonate which combines bone anti-catabolic and anabolic functions
Simona Rapposelli et al.
SCIENTIFIC REPORTS (2017)
The Beneficial Effects of Bisphosphonate-enoxacin on Cortical Bone Mass and Strength in Ovariectomized Rats
Xuqiang Liu et al.
FRONTIERS IN PHARMACOLOGY (2017)
Comparison of fracture risk assessment tools in older men without prior hip or spine fracture: the MrOS study
Margaret L. Gourlay et al.
ARCHIVES OF OSTEOPOROSIS (2017)
SIRT1 is a positive regulator of in vivo bone mass and a therapeutic target for osteoporosis
Kayvan Zainabadi et al.
PLOS ONE (2017)
Hydrogen Sulfide Is a Novel Regulator of Bone Formation Implicated in the Bone Loss Induced by Estrogen Deficiency
Francesco Grassi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Clinical utility of routine laboratory testing to identify possible secondary causes in older men with osteoporosis: the Osteoporotic Fractures in Men (MrOS) Study
H. A. Fink et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Teriparatide in patients with osteoporosis and type 2 diabetes
Ann V. Schwartz et al.
BONE (2016)
Treatment needs and current options for postmenopausal osteoporosis
Luigi Gennari et al.
EXPERT OPINION ON PHARMACOTHERAPY (2016)
Risk Factors for Hip Fracture in Older Men: The Osteoporotic Fractures in Men Study (MrOS)
Jane A. Cauley et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair
Monica Florio et al.
NATURE COMMUNICATIONS (2016)
Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis
F. Vescini et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2016)
Guidelines for the diagnosis, prevention and management of osteoporosis
M. Rossini et al.
REUMATISMO (2016)
Anabolic Bone Formation Via a Site-Specific Bone-Targeting Delivery System by Interfering With Semaphorin 4d Expression
Yufeng Zhang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
LRP receptor family member associated bone disease
N. Lara-Castillo et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2015)
Glycosylation Effects on FSH-FSHR Interaction Dynamics: A Case Study of Different FSH Glycoforms by Molecular Dynamics Simulations
Biswa Ranjan Meher et al.
PLOS ONE (2015)
The Kynurenine Pathway of Tryptophan Degradation is Activated During Osteoblastogenesis
Christopher Vidal et al.
STEM CELLS (2015)
Soluble Guanylate Cyclase as a Novel Treatment Target for Osteoporosis
Jisha Joshua et al.
ENDOCRINOLOGY (2014)
Resveratrol Increases Bone Mineral Density and Bone Alkaline Phosphatase in Obese Men: A Randomized Placebo-Controlled Trial
Marie Juul Ornstrup et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Clinician's Guide to Prevention and Treatment of Osteoporosis
F. Cosman et al.
OSTEOPOROSIS INTERNATIONAL (2014)
T Cell Costimulation Molecules CD80/86 Inhibit Osteoclast Differentiation by Inducing the IDO/Tryptophan Pathway
Aline Bozec et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Implications of expanding indications for drug treatment to prevent fracture in older men in United States: cross sectional and longitudinal analysis of prospective cohort study
Kristine E. Ensrud et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
SARC-F: A Simple Questionnaire to Rapidly Diagnose Sarcopenia
Theodore K. Malmstrom et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2013)
Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
Matthew R. Smith et al.
JOURNAL OF UROLOGY (2013)
WNT1 Mutations in Early-Onset Osteoporosis and Osteogenesis Imperfecta
Christine M. Laine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Circulating activin-A is elevated in postmenopausal women with low bone mass: the three-month effect of zoledronic acid treatment
A. D. Anastasilakis et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Osteoporosis in the European Union: medical management, epidemiology and economic burden
E. Hernlund et al.
ARCHIVES OF OSTEOPOROSIS (2013)
Idiopathic Osteoporosis in Men
Luigi Gennari et al.
CURRENT OSTEOPOROSIS REPORTS (2013)
Incidence rates of fragility hip fracture in middle-aged and elderly men and women in southern Norway
Andreas P. Diamantopoulos et al.
AGE AND AGEING (2012)
Osteoporosis and vertebral fractures in men aged 60-74 years
Morten Frost et al.
AGE AND AGEING (2012)
Evidence for safety and efficacy of risedronate in men with osteoporosis over 4 years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study
Steven Boonen et al.
BONE (2012)
Fracture risk assessment
Eugene McCloskey et al.
CLINICAL BIOCHEMISTRY (2012)
Hip fractures in Norway 1999-2008: time trends in total incidence and second hip fracture rates. A NOREPOS study
Tone K. Omsland et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2012)
Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline
Nelson B. Watts et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
A Randomized, Placebo-Controlled Study of the Effects of Denosumab for the Treatment of Men with Low Bone Mineral Density
Eric Orwoll et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Comparative Effectiveness of Drug Treatments to Prevent Fragility Fractures: A Systematic Review and Network Meta-Analysis
Mohammad Hassan Murad et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
Matthew R. Smith et al.
LANCET (2012)
Osteoprotection by semaphorin 3A
Mikihito Hayashi et al.
NATURE (2012)
Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis
Steven Boonen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Blocking antibody to the β-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesis
Ling-Ling Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Hip Fractures in the United States: 2008 Nationwide Emergency Department Sample
Sunny H. Kim et al.
ARTHRITIS CARE & RESEARCH (2012)
Activin Receptor Signaling: A Potential Therapeutic Target for Osteoporosis
Sutada Lotinun et al.
Current Molecular Pharmacology (2012)
Screening for Osteoporosis: US Preventive Services Task Force Recommendation Statement
Ned Calonge et al.
ANNALS OF INTERNAL MEDICINE (2011)
Follicle-stimulating hormone promotes RANK expression on human monocytes
Joseph G. Cannon et al.
CYTOKINE (2011)
Bone Mass in Subjects with Klinefelter Syndrome: Role of Testosterone Levels and Androgen Receptor Gene CAG Polymorphism
Alberto Ferlin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
A Rate-Limiting Role for Dickkopf-1 in Bone Formation and the Remediation of Bone Loss in Mouse and Primate Models of Postmenopausal Osteoporosis by an Experimental Therapeutic Antibody
Helmut Glantschnig et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Hip Fracture in Men-Survival and Subsequent Fractures: A Cohort Study with 22-Year Follow-Up
My von Friesendorff et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2011)
Once-Yearly Zoledronic Acid in Older Men Compared with Women with Recent Hip Fracture
Steven Boonen et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2011)
Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis
Aline G. Costa et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
Medical costs of osteoporosis in the elderly Medicare population
S. W. Blume et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Testosterone and the Male Skeleton: A Dual Mode of Action
Mieke Sinnesael et al.
JOURNAL OF OSTEOPOROSIS (2011)
Follicle-stimulating hormone, interleukin-1, and bone density in adult women
Joseph G. Cannon et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2010)
Further evidence for direct pro-resorptive actions of FSH
Li Sun et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
FSH-receptor isoforms and FSH-dependent gene transcription in human monocytes and osteoclasts
Lisa J. Robinson et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
A soluble activin receptor Type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeys
Sutada Lotinun et al.
BONE (2010)
Efficacy and safety of monthly ibandronate in men with low bone density
Eric S. Orwoll et al.
BONE (2010)
Cadmium, follicle-stimulating hormone, and effects on bone in women age 42-60 years, NHANES III
Carolyn M. Gallagher et al.
ENVIRONMENTAL RESEARCH (2010)
FSHR gene polymorphisms influence bone mineral density and bone turnover in postmenopausal women
Domenico Rendina et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D
David M. Slovik et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Perspective how many women have osteoporosis?
L. Joseph Melton et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Effects of the Src Kinase Inhibitor Saracatinib (AZD0530) on Bone Turnover in Healthy Men: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Ascending-Dose Phase I Trial
Rosemary A. Hannon et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Sex steroid metabolism in the regulation of bone health in men
Liesbeth Vandenput et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Adverse Events Associated with Testosterone Administration
Shehzad Basaria et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effects of Teriparatide Versus Alendronate for Treating Glucocorticoid-Induced Osteoporosis Thirty-Six-Month Results of a Randomized, Double-Blind, Controlled Trial
Kenneth G. Saag et al.
ARTHRITIS AND RHEUMATISM (2009)
Single-Dose, Randomized, Double-Blind, Placebo-Controlled Study of ACE-011 (ActRIIA-IgG1) in Postmenopausal Women
Jon Ruckle et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Once-Weekly Risedronate in Men With Osteoporosis: Results of a 2-Year, Placebo-Controlled, Double-Blind, Multicenter Study
Steven Boonen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
Matthew R. Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study
Johann D. Ringe et al.
RHEUMATOLOGY INTERNATIONAL (2009)
A reference standard for the description of osteoporosis
John A. Kanis et al.
BONE (2008)
The relationship between gonadotrophins, gonadal hormones and bone mass in men
N. Karim et al.
CLINICAL ENDOCRINOLOGY (2008)
Osteoporosis in men
Sundeep Khosla et al.
ENDOCRINE REVIEWS (2008)
Osteoporosis in men
Peter R. Ebeling
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Cost-effective osteoporosis treatment thresholds: the United States perspective
A. N. A. Tosteson et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Teriparatide or alendronate in glucocorticoid-induced osteoporosis
Kenneth G. Saag et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Femoral neck BMD is a strong predictor of hip fracture susceptibility in elderly men and women because it detects cortical bone instability: The Rotterdam study
Fernando Rivadeneira et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men
John T. Schousboe et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Prior fractures are common in patients with subsequent hip fractures
Beatrice J. Edwards et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2007)
Bone Microenvironment Specific Roles of ITAM Adapter Signaling during Bone Remodeling Induced by Acute Estrogen-Deficiency
Yalei Wu et al.
PLOS ONE (2007)
Osteoporosis in men
Luigi Gennari et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2007)
Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025
Russel Burge et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Predictors of non-spine fracture in elderly men: The MrOS study
Cora E. Lewis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Risk of subsequent fracture after low-trauma fracture in men and women
Jacqueline R. Center et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures
O. Johnell et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation
Jameel Iqbal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Clinical review: Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials
Michal J. Tracz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Does Alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women
AM Sawka et al.
BMC MUSCULOSKELETAL DISORDERS (2005)
Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy
JM Kaufman et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Raloxifene treatment is associated with increased serum estradiol and decreased bone remodeling in healthy middle-aged men with low sex, hormone levels
B Uebelhart et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Aromatase activity and bone homeostasis in men
L Gennari et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men:: Effects on bone metabolism
L Gennari et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Weekly oral alendronic acid in male osteoporosis
PD Miller et al.
CLINICAL DRUG INVESTIGATION (2004)
Alendronate treatment in men with primary osteoporosis: A three-year longitudinal study
S Gonnelli et al.
CALCIFIED TISSUE INTERNATIONAL (2003)
Reproductive hormones in the early menopausal transition: Relationship to ethnicity, body size, and menopausal status
JF Randolph et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN
MR Sowers et al.
OSTEOPOROSIS INTERNATIONAL (2003)
Deficient acquisition of bone during maturation underlies idiopathic osteoporosis in men: Evidence from a three-generation family study
I Van Pottelbergh et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis
E Orwoll et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Osteoporosis in men and women: A story about bone mineral density thresholds and hip fracture risk
CEDH De Laet et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Clinical use of bone densitometry - Scientific review
SR Cummings et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Genetics of male osteoporosis
L Gennari et al.
CALCIFIED TISSUE INTERNATIONAL (2001)
Decreased c-Src expression enhances osteoblast differentiation and bone formation
M Marzia et al.
JOURNAL OF CELL BIOLOGY (2000)
Alendronate for the treatment of osteoporosis in men
E Orwoll et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Parathyroid hormone as a therapy for idiopathic osteoporosis in men: Effects on bone mineral density and bone markers
ES Kurland et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Share Paper
